PI3Kδ inhibitor idelalisib in combination with BTK inhibitor ONO/GS-4059 in diffuse large B cell lymphoma with acquired resistance to PI3Kδ and BTK inhibitors

por Yahiaoui, Anella, Meadows, Sarah A., Sorensen, Rick A., Cui, Zhi-Hua, Keegan, Kathleen S., Brockett, Robert, Chen, Guang, Quéva, Christophe, Li, Li, Tannheimer, Stacey L.
Publicado 2017